DoW Autism Clinical Trial Award
This grant funds clinical trials aiming to significantly improve autism treatment or management, requiring community collaboration and encouraging partnerships between experienced and early-career investigators.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 27, 2026: Pre-Application (Preproposal) | October 22, 2026: Full application | October 27, 2026: End of application verification period
Funding Amounts: Total program funding: $3,250,000; up to $1.5M for Single PI, up to $1.75M for Partnering PI Option, max 4 years
Summary: Supports rapid implementation of clinical trials with potential for significant impact on autism treatment or management.
Key Information: Community collaboration is required; early-career investigator partnering option available for higher funding.
Description
This opportunity funds clinical trials under the FY26 Autism Research Program (ARP) Clinical Trial Award, aiming to accelerate impactful research on autism treatment and management. Funding supports a broad range of clinical trials, from small proof-of-concept studies to large-scale efficacy trials. The program encourages projects that address specific areas of interest relevant to the autism community, including the needs of military families, quality of life, diagnosis, intervention, and both pharmacological and non-pharmacological treatments. A distinctive feature of this award is the requirement for meaningful community collaboration throughout the research process, as well as a special funding track for early-career investigators partnered with experienced mentors.
